활성화가능 항-PDL1 항체, 및 이의 이용 방법

본 발명은 PDL1에 특이적으로 결합하는 활성화가능 항체 및 다양한 치료, 진단 및 예방 증상에서 이들 활성화가능 항-PDL1 항체를 이용하는 방법에 전반적으로 관계한다. The invention relates generally to activatable antibodies that specifically bind to PDL1 and methods of making and using these anti-PDL1 activatable antibodies in a variety of therapeutic, diagnostic and...

Full description

Saved in:
Bibliographic Details
Main Authors ZHENG BEIYAO, HUMPHREY RACHEL, CARMAN LORI, BALINSKI KATHE, WILL MATTHIAS
Format Patent
LanguageKorean
Published 17.02.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 본 발명은 PDL1에 특이적으로 결합하는 활성화가능 항체 및 다양한 치료, 진단 및 예방 증상에서 이들 활성화가능 항-PDL1 항체를 이용하는 방법에 전반적으로 관계한다. The invention relates generally to activatable antibodies that specifically bind to PDL1 and methods of making and using these anti-PDL1 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.
AbstractList 본 발명은 PDL1에 특이적으로 결합하는 활성화가능 항체 및 다양한 치료, 진단 및 예방 증상에서 이들 활성화가능 항-PDL1 항체를 이용하는 방법에 전반적으로 관계한다. The invention relates generally to activatable antibodies that specifically bind to PDL1 and methods of making and using these anti-PDL1 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.
Author ZHENG BEIYAO
CARMAN LORI
BALINSKI KATHE
HUMPHREY RACHEL
WILL MATTHIAS
Author_xml – fullname: ZHENG BEIYAO
– fullname: HUMPHREY RACHEL
– fullname: CARMAN LORI
– fullname: BALINSKI KATHE
– fullname: WILL MATTHIAS
BookMark eNrjYmDJy89L5WSwfDtzzpuWjW9nTnm1oeF111KFt1PX6ga4-BiCGG82bdFReL2hX-HN3C1v5s4AU7NWAkVWvt40lYeBNS0xpziVF0pzMyi7uYY4e-imFuTHpxYXJCan5qWWxHsHGRkYGRgYGJpZWFo6GhOnCgBP4z6Z
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20200016899A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20200016899A3
IEDL.DBID EVB
IngestDate Fri Oct 04 04:58:23 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20200016899A3
Notes Application Number: KR20197038758
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200217&DB=EPODOC&CC=KR&NR=20200016899A
ParticipantIDs epo_espacenet_KR20200016899A
PublicationCentury 2000
PublicationDate 20200217
PublicationDateYYYYMMDD 2020-02-17
PublicationDate_xml – month: 02
  year: 2020
  text: 20200217
  day: 17
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies CYTOMX THERAPEUTICS, INC
RelatedCompanies_xml – name: CYTOMX THERAPEUTICS, INC
Score 3.2298617
Snippet 본 발명은 PDL1에 특이적으로 결합하는 활성화가능 항체 및 다양한 치료, 진단 및 예방 증상에서 이들 활성화가능 항-PDL1 항체를 이용하는 방법에 전반적으로 관계한다. The invention relates generally to activatable antibodies that...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 활성화가능 항-PDL1 항체, 및 이의 이용 방법
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200217&DB=EPODOC&locale=&CC=KR&NR=20200016899A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSbI0S0pMNjbQNTVLM9Y1AcaDbhKwma2bZggsGU1NzcyTk0EbhX39zDxCTbwiTCOYGHJge2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGrR3DF5xYK7m4mTrGuDv4u-s5uxs6x2k5hcEkQM2b4DdC0dmBlZgQ9octADMNcwJtC-lALlScRNkYAsAmpdXIsTAlJ0vzMDpDLt7TZiBwxc65Q1kQnNfsQiD5duZc960bHw7c8qrDQ2vu5YqvJ26VjfAxccQxHizaYuOwusN_Qpv5m55M3cGmJq1Eiiy8vWmqaIMym6uIc4eukA3xMO9HO8dhOxgYzEGlrz8vFQJBoXElOTENGCzIjkZ2JJJtUixME0DnV8D7KalmpoYp6RKMsjgM0kKv7Q0AxeIC1qVbGguw8BSUlSaKgusdEuS5MBhBQCm5ZJV
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSbI0S0pMNjbQNTVLM9Y1AcaDbhKwma2bZggsGU1NzcyTk0EbhX39zDxCTbwiTCOYGHJge2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGrR3DF5xYK7m4mTrGuDv4u-s5uxs6x2k5hcEkQM2b4DdC0dmBlZgI9sCdNK-a5gTaF9KAXKl4ibIwBYANC-vRIiBKTtfmIHTGXb3mjADhy90yhvIhOa-YhEGy7cz57xp2fh25pRXGxpedy1VeDt1rW6Ai48hiPFm0xYdhdcb-hXezN3yZu4MMDVrJVBk5etNU0UZlN1cQ5w9dIFuiId7Od47CNnBxmIMLHn5eakSDAqJKcmJacBmRXIysCWTapFiYZoGOr8G2E1LNTUxTkmVZJDBZ5IUfml5Bk6PEF-feB9PP29pBi6QFGiFsqG5DANLSVFpqiywAi5JkgOHGwCrwJVF
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=%ED%99%9C%EC%84%B1%ED%99%94%EA%B0%80%EB%8A%A5+%ED%95%AD-PDL1+%ED%95%AD%EC%B2%B4%2C+%EB%B0%8F+%EC%9D%B4%EC%9D%98+%EC%9D%B4%EC%9A%A9+%EB%B0%A9%EB%B2%95&rft.inventor=ZHENG+BEIYAO&rft.inventor=HUMPHREY+RACHEL&rft.inventor=CARMAN+LORI&rft.inventor=BALINSKI+KATHE&rft.inventor=WILL+MATTHIAS&rft.date=2020-02-17&rft.externalDBID=A&rft.externalDocID=KR20200016899A